Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study

Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) increase atherosclerotic cardiovascular disease risk. Cholesterol efflux capacity (CEC) is a key metric of the anti-atherosclerotic functionality of high-density lipoproteins (HDL). The present study aimed to delineate if T2DM and MetS cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Annema, Wijtske, Dikkers, Arne, de Boer, Jan Freark, van Greevenbroek, Marleen M. J., van der Kallen, Carla J. H., Schalkwijk, Casper G., Stehouwer, Coen D. A., Dullaart, Robin P. F., Tietge, Uwe J. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897620/
https://www.ncbi.nlm.nih.gov/pubmed/27270665
http://dx.doi.org/10.1038/srep27367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897620/
https://www.ncbi.nlm.nih.gov/pubmed/27270665
http://dx.doi.org/10.1038/srep27367

Ejemplares similares